SCHEMBL16489289

SCHEMBL16489289

CCc1ccc(/C(N)=N/O)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.39
MAP2K2 P36507 1/20 0.39
MAP2K1 Q02750 1/20 0.39
PLAU P00749 1/20 0.38
TRPA1 O75762 1/20 0.37
KLKB1 P03952 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.35
TAAR1 Q96RJ0 1/20 0.34
RARB P10826 2/20 0.33
IDO1 P14902 1/20 0.33
RARA P10276 1/20 0.33
RARG P13631 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
RAD52 P43351 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MGLL Q99685 1/20 0.33
KDM1A O60341 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16080631 0.84 KLKB1 (0.38) GAAPLAUKLKB1KDM1A
SCHEMBL15633641 0.84 KLKB1 (0.38) GAAPLAUKLKB1KDM1A
SCHEMBL15633640 0.84 KLKB1 (0.38) GAAPLAUKLKB1KDM1A
SCHEMBL13631338 0.80 IDO1 (0.44) MAP2K2MAP2K1PLAUTRPA1KLKB1
SCHEMBL27894275 0.79 TRPA1 (0.37) MAP2K2MAP2K1TRPA1RARBRARA
SCHEMBL10211142 0.79 DGAT1 (0.55) MAP2K2MAP2K1TRPA1RARBRARA
SCHEMBL29361102 0.77 GAA (0.42) GAAMAP2K2MAP2K1SMN1; SMN2KMT2A
SCHEMBL17730394 0.77 GAA (0.42) GAAMAP2K2MAP2K1SMN1; SMN2KMT2A
SCHEMBL17737798 0.77 GAA (0.42) GAAMAP2K2MAP2K1SMN1; SMN2KMT2A
SCHEMBL17730395 0.77 GAA (0.42) GAAMAP2K2MAP2K1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9266828-B2 Inhibitors of Furin and other pro-protein convertases SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2016-02-23 US disclosed
US-20150073054-A1 INHIBITORS OF FURIN AND OTHER PRO-PROTEIN CONVERTASES SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 2015-03-12 US disclosed
US-20150051138-A1 INHIBITORS OF FURIN AND OTHER PRO-PROTEIN CONVERTASES SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2015-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051138-A1 INHIBITORS OF FURIN AND OTHER PRO-PROTEIN CONVERTASES FURIN, PREP, PCSK6 GAA 1644/4885MAP2K2 2378/4885MAP2K1 2444/4885
US-20150073054-A1 INHIBITORS OF FURIN AND OTHER PRO-PROTEIN CONVERTASES FURIN, PREP, PCSK6 GAA 1644/4885MAP2K2 2378/4885MAP2K1 2444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.